Medixen Pharma Private Limited
About Medixen Pharma Private Limited
Data last updated:
Medixen Pharma Private Limited is a private limited company based in Delhi, India. It was incorporated on 24 August 2024.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U46497DL2024PTC435829.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Uday Shankar Singh (Managing Director) and Prabha Singh.
Its last annual general meeting (AGM) was held on 30 December 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Yc Co – Working Space 3rd F, Plot.94 Dwarka Sector.13, Delhi, India – 110075.
As per the financials filed for FY 2025, the company reported a revenue of ₹29,024. For the same year it recorded a net loss of ₹71,444 (net margin -246.2%) and EBITDA of -₹71,444 (EBITDA margin -246.2%).
As per MCA filings, the company has open charges of ₹5 Lakh on record.
Company details
Contact details
Medixen Pharma Private Limited's registered office is in Delhi, Delhi.
- Registered AddressYc Co – Working Space 3rd F, Plot.94 Dwarka Sector.13, Delhi, India – 110075
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Medixen Pharma Private Limited
FY 2025 filings availableMedixen Pharma Private Limited reported revenue of ₹29,024 for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | -₹71,444 |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | -₹71,444 |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2024-25 |
|---|---|
| Profitability | |
| EBITDA Margin | -246.2% |
| Net Profit Margin | -246.2% |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Medixen Pharma Private Limited, buy the company report.
Board of directors of Medixen Pharma Private Limited
Medixen Pharma has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Prabha Singh | Director | 24 Aug 2024 | 2 Years 2 Months | Current |
| Uday Shankar Singh | Managing Director | 24 Aug 2024 | 2 Years 2 Months | Current |
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 16 Dec 2025 | 101206969 | Others | ₹5 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Medixen Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medixen Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Medixen Pharma Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Medixen Pharma Private Limited has 2 board changes on record since 2024: 2 appointments. The latest: Prabha Singh was appointed as Director on 24 Aug 2024.
Frequently asked questions
Medixen Pharma is an active private limited company based in Delhi, India. It was incorporated on 24 August 2024 (2+ years old) and is registered under CIN U46497DL2024PTC435829.
Medixen Pharma has 2 current directors:
- Uday Shankar Singh - Managing Director
- Prabha Singh - Director
The latest financial statements of Medixen Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 December 2025. Year-wise statements from FY 2025 are in the company report.
The CIN (Corporate Identification Number) of Medixen Pharma is U46497DL2024PTC435829. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medixen Pharma was incorporated on 24 August 2024, making it 2+ years old. It is registered with the Registrar of Companies, Delhi.
Prabha Singh was appointed as Director on 24 Aug 2024. Uday Shankar Singh was appointed as Managing Director on 24 Aug 2024.
The registered office of Medixen Pharma is at Yc Co – Working Space 3rd F, Plot.94 Dwarka Sector.13, Delhi, India – 110075.
Medixen Pharma has open charges of ₹5 Lakh and no satisfied charges on record as per latest MCA filings.
Medixen Pharma can be reached at its registered office: Yc Co – Working Space 3rd F, Plot.94 Dwarka Sector.13, Delhi, India – 110075.
Medixen Pharma is registered under the jurisdiction of the Registrar of Companies (ROC), Delhi.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
